Skip to main content
MENU
Program
Agenda
CE Information
Sponsors and Supporters
Sponsors and Exhibitors
Educational Grant Supporters
Media Center
Explore the CardioVascular Learning Network
Stay Informed
connect with us
+
Available Dates
February 27-March 1, 2025 | Salt Lake City, Utah
|
Stay Informed
MENU
Agenda
February 27-March 1, 2025 | Salt Lake City, Utah
Stay Informed
February 27-March 1, 2025 | Salt Lake City, Utah
Thursday February 22, 2024
2:00 PM – 5:00 PM
Meeting the Masters Fellows Symposium
Speaker
Eric Prystowsky
MD
Gregory Michaud
MD
Melvin Scheinman
MD
5:00 PM – 5:30 PM
Refreshment Break in Foyer
5:30 PM – 6:30 PM
Fellows Research Competition
Faculty
Sana Al-Khatib
MD, MHS
Friday February 23, 2024
6:30 AM – 7:30 AM
Registration
7:00 AM – 8:00 AM
Innovation Theater Breakfast (Non-CME): Improving Patient Experience Through Early Ambulation Following Atrial Fibrillation Ablation
Discussant
Amin Al-Ahmad
MD
+
8:10 AM – 9:25 AM
Session 1
Moderator
Andrew Krahn
MD FHRS
Melvin Scheinman
MD
8:10 AM – 8:15 AM
Welcome Remarks
8:15 AM – 8:20 AM
David E. Haines Memorial Address
8:20 AM – 8:30 AM
What could revolutionize AF management in the near future?
8:30 AM – 8:40 AM
Digital Health & Wearables in AF: What’s Needed to Really Disrupt
8:40 AM – 8:50 AM
When Will AI Integration Enter the New AF Guidelines?
8:50 AM – 9:00 AM
ADVENT Trial: PFA vs Thermal Ablation in paroxysmal AF
9:00 AM – 9:10 AM
Predictors of AF incidence and burden in patients with no CVD: an emphasis on early population-based interventions
9:10 AM – 9:25 AM
Open Discussion
9:25 AM – 10:25 AM
Session 2 - Roundtable: Every AF patient deserves at least a PVI
Discussant
Christian Mahnkopf
MD, PhD
Jason Andrade
MD FRCPC
Jeanne Poole
MD
John Mandrola
MD
Oussama Wazni
MD
Usman Rasheed Siddiqui
Moderator
Hugh Calkins
MD
Johannes Brachmann
MD PhD
10:30 AM – 10:45 AM
Exhibit Hall/Refreshment Break
+
10:50 AM – 11:55 AM
Session 3
Moderator
Andrea Russo
MD
Felix Hohendanner
MD, PhD
11:00 AM – 11:10 AM
CASTLE-HTx: Catheter Ablation versus Medical Therapy to Treat Atrial Fibrillation in End-stage Heart Failure
11:10 AM – 11:20 AM
Pulsed Field Ablation Beyond the Pulmonary Veins: Impact on AF ablation outcomes
11:20 AM – 11:30 AM
SMURDEN: a new treatment endpoint?
11:30 AM – 11:40 AM
Atrial fibrillation burden and timing of Medical Therapy in patients with screen-detected and clinically-diagnosed AF
11:40 AM – 11:55 AM
Open Discussion
12:00 PM – 1:00 PM
Industry-Supported Symposium Lunch - Treatment Strategies for Advanced AF: Impact on Heart Failure
Discussant
Eoin Donnellan
MD
Michael Riley
MD
Moderator
Nassir Marrouche
MD
Speaker
Christian Sohns
Prof.
David De Lurgio
MD
+
1:05 PM – 2:00 PM
Session 4
Moderator
Amin Al-Ahmad
MD
Tina Baykaner
MD, MPH
1:05 PM – 1:15 PM
Atrial high rate episodes: Should we always anticoagulate? NOAH-AFNET 6 and ATRISIA
1:15 PM – 12:55 PM
Epicardial Access in Atrial Fibrillation
1:25 PM – 1:05 PM
Customizing AF Management Based on Recognized Sex-Specific Outcome Variations
1:35 PM – 1:45 PM
Global challenges in AF treatment: what can we learn from each other?
1:45 PM – 2:00 PM
Open Discussion
+
2:00 PM – 2:55 PM
Session 5
Moderator
Ahmad Abdul Karim
MD
Douglas Packer
MD
2:00 PM – 2:10 PM
Completing the Castle Brick by Brick: Can Ablation break the HFpEF-AF Cycle?
2:10 PM – 2:20 PM
Managing Peri-Device Leaks Following Watchman Device
2:20 PM – 2:30 PM
Advantages of Devices in Detecting and Diagnosing AFIB: Examples of Practice
2:30 PM – 2:40 PM
Cardiac resynchronization therapy in patients with a prior history of atrial fibrillation: Insights from four major clinical trials.
2:40 PM – 2:55 PM
Open Discussion
3:00 PM – 3:15 PM
Exhibit Hall/Refreshment Break
+
3:20 PM – 4:15 PM
Session 6
Moderator
Gregory Michaud
MD
Swati Rao
MD
3:20 PM – 3:30 PM
Lesion Delivery and Scar Formation in Catheter Ablation for Atrial Fibrillation - The DECAAF II Trial
3:30 PM – 3:40 PM
Redefining AF Severity Using AI
3:40 PM – 3:50 PM
Morphological and Electrical Characterization of Atrial Cardiomyopathy
3:50 PM – 4:00 PM
AF and HFrEF; pace and ablate with left bundle branch pacing
4:00 PM – 4:15 PM
Open Discussion
+
4:15 PM – 5:00 PM
Session 7
Moderator
Christian Mahnkopf
MD, PhD
Thomas Deering
MD
4:15 PM – 4:25 PM
CIRCA-DOSE: Atrial Fibrillation Progression after Cryoballoon or Radiofrequency Ablation: what are the implications?
4:25 PM – 4:35 PM
Could Gene Therapy be the Future of Afib Treatment?
4:35 PM – 4:45 PM
Future directions in Pulsed Field Ablation
4:45 PM – 4:55 PM
Insights from the Prospective Multicenter REAL-AF Registry
4:55 PM – 5:00 PM
Open Discussion
5:00 PM – 5:30 PM
Exhibit Hall/Refreshment Break
5:30 PM – 6:15 PM
Session 8 - Roundtable and Live Case Review: Recent Advances in Stroke Prevention (Non-Accredited)
Discussant
Andrea Natale
MD
Emile Daoud
MD
Michael Riley
MD
Vivek Reddy
MD
Live Case Operator
Boris Schmidt
MD
Devi Nair
MD , FACC, FHRS
Julian Chun
MD
Moderator
Oussama Wazni
MD
6:15 PM – 6:35 PM
Break
+
6:45 PM – 7:40 PM
Session 9
Moderator
John Day
MD
6:45 PM – 6:55 PM
How Many Ablation Modalities Does a Center Need?
6:55 PM – 7:05 PM
Understanding patterns of compliance to remote monitoring strategies in CV studies
7:05 PM – 7:15 PM
PAC induced atrial remodelling
7:15 PM – 7:25 PM
What it takes to move AF ablation practice to the outpatient setting
7:25 PM – 7:40 PM
Open Discussion
Saturday February 24, 2024
6:30 AM – 7:30 AM
Registration
7:00 AM – 8:00 AM
Innovation Theater Breakfast (Non-Accredited): Implementing Volta AI Based Dispersion EGM Guided Strategies for the Complex Substrate Patient Population
Discussant
Devi Nair
MD , FACC, FHRS
Paul Zei
Moderator
Andrea Natale
MD
+
8:10 AM – 9:15 AM
Session 10
Moderator
Kamala Tamirisa
MD
Melanie Gunawardene
MD
8:10 AM – 8:20 AM
Complications of Pulsed Field Ablation: lessons learned from the multi-centre EU-PORIA registry
8:20 AM – 8:30 AM
The future of LAA closure: Exploring The Latest Innovations
8:30 AM – 8:40 AM
Neuromodulation in AF therapy: Current use and future perspectives
8:40 AM – 8:50 AM
Anticoagulation in subclinical AF: The ARTESIA trial
8:50 AM – 9:00 AM
Atrial fibrillation in pregnancy
9:00 AM – 9:15 AM
Open Discussion
9:15 AM – 9:40 AM
Session 11 - Roundtable: Time to implement advanced imaging for optimized anticoagulation strategies in AF
Discussant
Edip Gurol
MD, MSc
Elaine Hylek
MD MPH
Gaston Vergara
MD
Jason Andrade
MD FRCPC
Stavros Stavrakis
MD, PhD
Moderator
Fred Kusumoto
MD
Jeff Healey
MD
+
9:40 AM – 10:45 AM
Session 12
Moderator
Boris Schmidt
MD
Jodie Hurwitz
9:40 AM – 9:50 AM
Atrial ablation with stable, contiguous and sphere-by-sphere PFA applications
9:50 AM – 10:00 AM
Semaglutide in atrial fibrillation
10:00 AM – 10:10 AM
Optimizing Patient Selection for Combined Left Atrial Appendage Closure & AF Ablation
10:10 AM – 10:20 AM
Phenotypes in diastolic dysfunction: Is Cardiac Imaging Enough?
10:20 AM – 10:30 AM
15 years of MRI fibrosis imaging: Why is it not scalable yet?
10:30 AM – 10:45 AM
Open Discussion
10:50 AM – 11:05 AM
Exhibit Hall/Refreshment Break
11:10 AM – 11:45 AM
Session 13 - Roundtable: The hype around AI: Are we over-optimistic about the future of AI
Discussant
Chan Ho Lim
Felix Hohendanner
MD, PhD
Hamid Ghanbari
MD
Jorge Romero
MD
Moderator
John Mandrola
MD
Kenneth Ellenbogen
MD
+
11:45 AM – 12:50 PM
Session 14
Moderator
Kevin Makati
MD
Narendra Kanuru
MD
11:45 AM – 11:55 AM
Rhythm control as early as possible: but what does "early" really mean?
11:55 AM – 12:05 PM
Is atrial myopathy a reversible process?
12:05 PM – 12:15 PM
Utilizing Big Data to improve ablation outcomes: MIRA Study
12:15 PM – 12:25 PM
Potential role of device-based electrical therapies in AF with HF
12:25 PM – 12:35 PM
Initial Findings From the National Cardiovascular Data Registry of Atrial Fibrillation Ablation Procedures
12:35 PM – 12:50 PM
Open Discussion
1:00 PM – 2:00 PM
Innovation Theater Lunch (non-CME): QDOT MICRO™ Catheter Early Experience & Best Practice Sharing with Key Opinion Leaders
Discussant
Amin Al-Ahmad
MD
Andrea Natale
MD
Nassir Marrouche
MD
+
2:10 PM – 3:15 PM
Session 15
Moderator
Bassam Wanna
MD
Hamid Ghanbari
MD
2:10 PM – 2:20 PM
Utilizing Digital Biomarkers for Predicting and Understanding Atrial Myopathy
2:20 PM – 2:30 PM
Efficacy and safety of combined pulsed field and thermal ablations
2:30 PM – 2:40 PM
The New AF Guidelines
2:40 PM – 2:50 PM
Enhancing Ablation Outcomes: A Comprehensive Update on Left Atrial Ablation
2:50 PM – 3:05 PM
Open Discussion
+
3:05 PM – 4:00 PM
Session 16
Moderator
Gaston Vergara
MD
Moussa Mansour
MD
3:05 PM – 3:15 PM
Utilizing PPG in Managing AF: Tools and AI
3:15 PM – 3:25 PM
Time to Say Goodbye to ESUS and Atrial Cardiopathy Constructs: New RCT Data, Same Negative Results
3:25 PM – 3:35 PM
LAAO vs. OAC: Which Option is Gaining the Upper Hand in Recent Data?
3:35 PM – 3:45 PM
Multimodality AI: Examples of Implementation in AF
3:45 PM – 4:00 PM
Open Discussion
4:00 PM – 4:35 PM
Session 17 - Roundtable: Meet the presidents: How presidents of societies influence the management of AF
Discussant
Ali Oto
Andrea Russo
MD
Christine Albert
MD
Fred Kusumoto
MD
Jodie Hurwitz
Kenneth Ellenbogen
MD
Patricia Blake
FASAE,CAE
Sana Al-Khatib
MD, MHS
Thomas Deering
MD
Moderator
Douglas Packer
MD
4:40 PM – 4:55 PM
Refreshment Break
5:00 PM – 6:00 PM
Session 18 - Roundtable: Managing the risk of bleeding in my AF patient
Discussant
Bassam Wanna
MD
Jill Schaeffer
Mohamed Elshazly
Monique Mones Young
Will Cho
Moderator
Brent Wilson
MD, PhD
Christopher McGann
MD
6:00 PM – 6:40 PM
Session 19 - ROUNDTABLE: #ASKWAF
Discussant
Jared Bunch
Jill Schaeffer
Leslie Li
MD
Mellanie True Hills
Omar Kreidieh
MD
Paul Zei
Moderator
Edward Schloss
MD
Janet Han
MD, FACC, FHRS
Questions?
Contact